These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3395777)

  • 1. A double-blind, cross-over trial of O-(beta-hydroxyethyl) rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Faga A
    Br J Plast Surg; 1988 Jul; 41(4):444-5. PubMed ID: 3395777
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Piller NB; Morgan RG; Casley-Smith JR
    Br J Plast Surg; 1988 Jan; 41(1):20-7. PubMed ID: 3278764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
    Mann RJ
    Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
    Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
    J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
    Artaria LG
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
    [No Abstract]   [Full Text] [Related]  

  • 6. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
    Becker HM; Niedermaier G; Orend KH
    Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
    Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
    Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
    Stegmann W; Hubner K; Deichmann B; Muller B
    Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
    Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
    Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of benzopyrones in posttraumatic inflammations/Clinical double blind study in the postoperative treatment of episiotomy (author's transl)].
    Pethö A
    Arzneimittelforschung; 1981; 31(8):1303-7. PubMed ID: 7028045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial of hydroxyethylrutosides in Menière's disease.
    Moser M; Ranacher G; Wilmot TJ; Golden GJ
    J Laryngol Otol; 1984 Mar; 98(3):265-72. PubMed ID: 6366100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
    de Jongste AB; Jonker JJ; Huisman MV; ten Cate JW; Azar AJ
    Thromb Haemost; 1989 Nov; 62(3):826-9. PubMed ID: 2688186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of the anti-oedematous effect of O-(beta-hydroxyethyl)-rutosides in healthy volunteers.
    Rehn D; Hennings G; Nocker W; Diebschlag W
    Eur J Clin Pharmacol; 1991; 40(6):625-7. PubMed ID: 1884746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 18. Benzo-pyrones in the treatment of chronic schizophrenic diseases.
    Casley-Smith JR; Casley-Smith JR; Johnson AF; Weston FK
    Psychiatry Res; 1986 Jul; 18(3):267-73. PubMed ID: 2875479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J
    Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and quantification of O-(beta-hydroxyethyl)-rutosides by mass spectrometry selected ion monitoring.
    Kuhnz W; Rembold H
    Biomed Mass Spectrom; 1980 Jun; 7(6):269-72. PubMed ID: 7426692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.